ID

16544

Description

Study Sponsor: Astellas Study Title Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study Medicine or Vaccine (generic name) capsaicin Sponsor Identification Number QTZ-EC-0002 Trial Registry Identification Number(#'s) NCT01416116 EudraCT Number: 2010-023258-34 Medical Condition Neuropathic pain Phase Phase 4 http://clinicaltrials.gov/show/NCT01416116 Screening Visit, Form 1/4: Date of Visit Screening Status Informed Consent 1 Demographics Medical and Surgical History

Link

http://clinicaltrials.gov/show/NCT01416116

Keywords

  1. 7/21/16 7/21/16 -
  2. 7/23/16 7/23/16 -
Uploaded on

July 23, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Screening Visit Form 1/4 Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study NCT01416116

Screening Visit Form 1/4 Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study NCT01416116

Date of Visit
Description

Date of Visit

Date of Visit
Description

Field name: VDDT

Data type

date

Screening Status
Description

Screening Status

Is the subject a screen failure (signed an informed consent but was not randomized)?
Description

Field Name: DSYN

Data type

integer

Alias
UMLS CUI [1]
C1710476
Reason for Not Meeting Admission Criteria
Description

Field Name: SFDECOD

Data type

integer

Alias
UMLS CUI [1,1]
C0030673
UMLS CUI [1,2]
C0392360
If 'Other' specify
Description

Field Name: SFOTHSP

Data type

text

Alias
UMLS CUI [1]
C0205394
Informed Consent 1
Description

Informed Consent 1

Date of Informed Consent
Description

DSSTDT

Data type

date

Alias
UMLS CUI [1]
C2985782
Demographics
Description

Demographics

Sex
Description

Sex

Data type

text

Alias
UMLS CUI [1]
C0079399
Birth Date
Description

Field Name: BRTHDT

Data type

date

Alias
UMLS CUI [1]
C0421451
Age
Description

Field Name: Age

Data type

integer

Measurement units
  • Years
Alias
UMLS CUI [1]
C0001779
Years
Race
Description

Field Name :RACE

Data type

integer

Alias
UMLS CUI [1]
C0034510
If 'Other', specify
Description

Field Name: RACEOTH

Data type

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0034510
Medical and Surgical History
Description

Medical and Surgical History

Is there any past or present Medical Condition? If 'Yes', please provide details below
Description

Field Name: MHANY

Data type

integer

Alias
UMLS CUI [1]
C0012634
MedicalCondition, specify
Description

Field Name: MHTERM

Data type

text

Alias
UMLS CUI [1]
C0012634
Onset Date
Description

Field Name: MHSTDT

Data type

date

Alias
UMLS CUI [1]
C0574845
Is Medical Condition ongoing? If 'No', please provide 'Recovered Date'.
Description

Field Name: MHONGO

Data type

integer

Alias
UMLS CUI [1,1]
C0549178
UMLS CUI [1,2]
C0012634
Recovered Date
Description

Field Name: MHENDT

Data type

date

Alias
UMLS CUI [1,1]
C0237820
UMLS CUI [1,2]
C0011008

Similar models

Screening Visit Form 1/4 Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study NCT01416116

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Date of Visit
Date of Visit
Item
Date of Visit
date
Item Group
Screening Status
Item
Is the subject a screen failure (signed an informed consent but was not randomized)?
integer
C1710476 (UMLS CUI [1])
Code List
Is the subject a screen failure (signed an informed consent but was not randomized)?
CL Item
No (0)
CL Item
Yes (1)
Item
Reason for Not Meeting Admission Criteria
integer
C0030673 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
Reason for Not Meeting Admission Criteria
CL Item
Not fulfill inclusion or exclusion criteria (1 )
CL Item
Untoward Medical Symptoms (3 )
CL Item
Subject lost to follow up (7 )
CL Item
Other (99 )
CL Item
Withdrawal of consent (6 )
Other
Item
If 'Other' specify
text
C0205394 (UMLS CUI [1])
Item Group
Informed Consent 1
Date of Informed Consent
Item
Date of Informed Consent
date
C2985782 (UMLS CUI [1])
Item Group
Demographics
Item
Sex
text
C0079399 (UMLS CUI [1])
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Birth Date
Item
Birth Date
date
C0421451 (UMLS CUI [1])
Age
Item
Age
integer
C0001779 (UMLS CUI [1])
Item
Race
integer
C0034510 (UMLS CUI [1])
Code List
Race
CL Item
White (1 )
CL Item
Black or African American (3 )
CL Item
Asian (4 )
CL Item
American Indian or Alaskan Native (5 )
CL Item
Native Hawaiian or Other Pacific Islander (6 )
CL Item
Other (99 )
Other race
Item
If 'Other', specify
text
C0205394 (UMLS CUI [1,1])
C0034510 (UMLS CUI [1,2])
Item Group
Medical and Surgical History
Item
Is there any past or present Medical Condition? If 'Yes', please provide details below
integer
C0012634 (UMLS CUI [1])
Code List
Is there any past or present Medical Condition? If 'Yes', please provide details below
CL Item
No (0 )
CL Item
Yes (1 )
Medical Condition
Item
MedicalCondition, specify
text
C0012634 (UMLS CUI [1])
Onset Date
Item
Onset Date
date
C0574845 (UMLS CUI [1])
Item
Is Medical Condition ongoing? If 'No', please provide 'Recovered Date'.
integer
C0549178 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Code List
Is Medical Condition ongoing? If 'No', please provide 'Recovered Date'.
CL Item
No (0 )
CL Item
Yes (1 )
date of recovery
Item
Recovered Date
date
C0237820 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial